Metraipolis › archive › dc_7a6404eaef1d
Rationale, design and baseline characteristics of participants in the OCEANIC-STROKE trial of FXIa inhibition for secondary stroke prevention — Europe PMC PMID:41614533
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41614533
- DOI
- 10.1093/esj/aakaf017
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-07T05:37:43.365Z
- SHA-256 of the archived text
465d3578adeac58c5689cb5805c2326240120044dd4fee83f1557ad65ade32d6- Stable URL of this page
https://metraipolis.com/documento/dc_7a6404eaef1d
How to cite
Rationale, design and baseline characteristics of participants in the OCEANIC-STROKE trial of FXIa inhibition for secondary stroke prevention — Europe PMC PMID:41614533 — Europe PMC (en), https://europepmc.org/article/MED/41614533 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_7a6404eaef1d (Metraipolis archive dc_7a6404eaef1d, sha256 465d3578adeac58c5689cb5805c2326240120044dd4fee83f1557ad65ade32d6)
BibTeX
@misc{dc7a6404eaef1d,
title = {Rationale, design and baseline characteristics of participants in the OCEANIC-STROKE trial of FXIa inhibition for secondary stroke prevention — Europe PMC PMID:41614533},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41614533},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_7a6404eaef1d; sha256 465d3578adeac58c5689cb5805c2326240120044dd4fee83f1557ad65ade32d6},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41614533. Agents can read the archived copy with the MCP tool read_document.